PERSPECTA

News from every angle

← Back to headlines

Rigel Forecasts $275M-$290M Total Revenue for 2026 Amid Debt Restructuring

Rigel Pharmaceuticals projects total revenue of $275 million to $290 million for 2026, alongside efforts to restructure its debt and regain RIPK1 rights.

6 May, 11:52 — 6 May, 11:52
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed11h ago

Rigel projects $275M-$290M 2026 total revenue while restructuring debt and regaining RIPK1 rights

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

No service cuts for unpaid power bills until July – ERC

just now

Philippine Unemployment Steady in March Amid Energy Crisis

just now

Agricultural Company Files Cyberlibel, Defamation Complaints Against Farmers' Groups

just now